Patents by Inventor Wendy Hirschelman

Wendy Hirschelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8106016
    Abstract: The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: January 31, 2012
    Assignee: Shire LLC
    Inventors: James Scott Moncrief, Suma Krishnan, Travis Mickle, Christopher Lauderback, Sanjib Bera, Sven Guenther, Wendy Hirschelman
  • Publication number: 20110136742
    Abstract: The invention provides antidepressant prodrugs comprising an antidepressant conjugated to one or more amino acids. The invention also relates to pharmaceutical compositions comprising an antidepressant prodrug, and to methods of preparing and using the same.
    Type: Application
    Filed: February 22, 2007
    Publication date: June 9, 2011
    Inventors: Travis Mickle, Wendy Hirschelman Severs
  • Publication number: 20070203055
    Abstract: The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.
    Type: Application
    Filed: December 8, 2006
    Publication date: August 30, 2007
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Scott Moncrief, Christopher Lauderback, Sanjib Bera, Sven Guenther, Wendy Hirschelman
  • Publication number: 20070066537
    Abstract: The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.
    Type: Application
    Filed: September 30, 2004
    Publication date: March 22, 2007
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christopher Lauderback, Thomas Piccariello, Sanjib Bera, Sven Guenther, Wendy Hirschelman
  • Patent number: 7169752
    Abstract: The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: January 30, 2007
    Assignee: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Scott Moncrief, Christopher Lauderback, Sanjib Bera, Sven Guenther, Wendy Hirschelman
  • Publication number: 20050176644
    Abstract: The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.
    Type: Application
    Filed: September 30, 2004
    Publication date: August 11, 2005
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christopher Lauderback, Sanjib Bera, Sven Guenther, Wendy Hirschelman